Please assess the completion status of the following clinical trial:

Trial Title: The Pain Pen for Breakthrough Cancer Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Stable cancer pain requiring the equivalent of 60-1000 mg oral morphine/day~* 1-4 breakthrough pain episodes/day~* Patients must be able, in the opinion of the investigator, to fully comply with trial requirements~* Patients who have given written informed consent~Exclusion Criteria:~* Uncontrolled pain~* Women who are pregnant, lactating or intend to become pregnant~* Cardiopulmonary disease that would increase the risk of opioids~* Neurologic or psychiatric disease that would compromise data collection~* Recently started chemotherapy or radiotherapy in as far as it would be effective in lowering breakthrough pain

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).